India to United States: Fulvestrant Export Trade Route
India has recorded 31 verified shipments of Fulvestrant exported to United States, representing a combined trade value of $4.0M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $128.9K USD. The leading Indian exporter is ALEMBIC PHARMACEUTICALS LIMITED, which accounts for 36% of total export value with 7 shipments worth $1.5M USD. On the buying side, J KNIPPER COMPANY is the largest importer in United States with $1.1M USD in purchases. The top 3 suppliers — ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED — together control 74% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Fulvestrant corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $4.0M USD. The route is dominated by ALEMBIC PHARMACEUTICALS LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's fulvestrant manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $128.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #3 among India's top fulvestrant export destinations globally.
On the import side, key buyers of Indian fulvestrant in United States include J KNIPPER COMPANY, XXNEAXXEU XXMITXX, DR REDDYS LABORATORIES INC and 14 others. J KNIPPER COMPANY is the single largest importer with 5 shipments valued at $1.1M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+28.8%
- Demand growth+24.1%
- Regulatory ease67/100
Top 10 Indian Fulvestrant Exporters to United States
Showing top 10 of 12 Indian suppliers exporting Fulvestrant to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LIMITED Avg $207.5K per shipment | 7 | $1.5M | 36.4% |
| 2 | DR REDDYS LABORATORIES LIMITED Avg $176.3K per shipment | 5 | $881.5K | 22.1% |
| 3 | AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED Avg $156.3K per shipment | 4 | $625.2K | 15.7% |
| 4 | DR REDDY S LABORATORIES LIMITED Avg $166.5K per shipment | 2 | $333.0K | 8.3% |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED Avg $274.5K per shipment | 1 | $274.5K | 6.9% |
| 6 | INTAS PHARMACEUTICALS LIMITED Avg $64.3K per shipment | 4 | $257.0K | 6.4% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $83.3K per shipment | 2 | $166.7K | 4.2% |
| 8 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $2.3K per shipment | 1 | $2.3K | 0.1% |
| 9 | KOIT BIOPHARMA PRIVATE LIMITED Avg $947 per shipment | 2 | $1.9K | 0.0% |
| 10 | PRANONNE HEALTH CARE Avg $140 per shipment | 1 | $140 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting fulvestrant to United States, ranked by total trade value. The listed exporters are: ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED, DR REDDY S LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, PRANONNE HEALTH CARE. ALEMBIC PHARMACEUTICALS LIMITED is the dominant supplier with 7 shipments worth $1.5M USD, giving it a 36% market share. The top 3 suppliers together account for 74% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to United States Fulvestrant export route.
Top 10 Fulvestrant Importers in United States
Showing top 10 of 17 known buyers in United States receiving Fulvestrant shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fulvestrant in United States include J KNIPPER COMPANY, XXNEAXXEU XXMITXX, DR REDDYS LABORATORIES INC, XX REXXY SXXABOXXTORXXS IXX, DR REDDY S LABORATORIES INC, among 17 total buyers. The largest importer is J KNIPPER COMPANY, accounting for $1.1M USD across 5 shipments — representing 28% of all fulvestrant imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | J KNIPPER COMPANY | 5 | $1.1M | 28.3% |
| 2 | XXNEAXXEU XXMITXX | 4 | $625.2K | 15.7% |
| 3 | DR REDDYS LABORATORIES INC | 3 | $595.3K | 14.9% |
| 4 | XX REXXY SXXABOXXTORXXS IXX | 2 | $333.0K | 8.3% |
| 5 | DR REDDY S LABORATORIES INC | 2 | $286.2K | 7.2% |
| 6 | EUGIA US LLC | 1 | $274.5K | 6.9% |
| 7 | J KNIPPER CO | 1 | $197.6K | 4.9% |
| 8 | AMERISOURCE HEALTH SERVICES | 3 | $181.7K | 4.5% |
| 9 | Amneal EU Limited | 2 | $166.7K | 4.2% |
| 10 | AMERICAN HEALTH PACKAGING | 1 | $124.2K | 3.1% |
Showing top 10 of 17 Fulvestrant importers in United States on this route.
Top 10 Fulvestrant Formulations Imported by United States
Showing top 10 of 18 product formulations shipped on the India to United States Fulvestrant route, ranked by trade value
United States imports a wide range of fulvestrant formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FULVESTRANT 250 MG/5 ML INJECTION — accounts for $1.2M USD across 7 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FULVESTRANT 250 MG/5 ML INJECTION | 7 | $1.2M | 30.4% |
| 2 | FULVESTRANT INJECTION 250MG/5ML 50MG/ML | 2 | $711.4K | 17.8% |
| 3 | FULVESTRANT INJECTION 250 MG/5ML | 4 | $625.2K | 15.7% |
| 4 | Fulvestrant Injection 250 mg 5 ML 50mg ML | 3 | $419.2K | 10.5% |
| 5 | FULVESTRANT INJECTION 250 MG/5 ML 50 MG/ML 3762 PAC2 NOS/PAC | 1 | $274.5K | 6.9% |
| 6 | FULVESTRANT INJECTION 250MG/5ML 50MG/ML [4151 PACK X 1 X 2 = 8302 NOS] | 1 | $197.6K | 4.9% |
| 7 | FULVESTRANT INJECTION,250 MG/5ML, | 2 | $166.7K | 4.2% |
| 8 | FULVESTRANT INJECTION 250MG 5ML 50MG ML 4097 PACK X 1X2 | 1 | $124.2K | 3.1% |
| 9 | PHA.DRU & MEDI, FULVESTRANT INJ.50MG/ML,5ML,2PFS(BPL-US EACH PREFILLED SYRINGE OF 5 ML CONTAINS: FULVESTRANT | 1 | $86.2K | 2.2% |
| 10 | PHARMACEUTICAL DRUGS AND MEDICINE., FULVESTRANT INJ.250MG/5ML 1X2PFS(AC-US EACH PREFILLED SYRINGE OF 5 ML CON | 1 | $75.4K | 1.9% |
Showing top 10 of 18 Fulvestrant formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 11 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's fulvestrant exports to United States are driven primarily by a handful of large-scale manufacturers. ALEMBIC PHARMACEUTICALS LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED — together account for 74% of total trade value on this route. The average shipment value of $128.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as fulvestrant injection 250mg/5ml 50mg/ml and fulvestrant injection 250 mg/5ml, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, J KNIPPER COMPANY is the largest importer with 5 shipments worth $1.1M USD — representing 28% of all fulvestrant imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.0M
- Avg. Shipment
- $128.9K
- Suppliers
- 12
- Buyers
- 17
- Transit (Sea)
- ~27 days
- Annual Growth
- +28.8%
Related Analysis
Reverse Direction
United States → India — Fulvestrant (Import)Other Fulvestrant Routes
Unlock the Full India to United States Fulvestrant Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 31 shipments on this route.
Frequently Asked Questions — India to United States Fulvestrant Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fulvestrant to United States?
The leading Indian exporters of Fulvestrant to United States are ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED. ALEMBIC PHARMACEUTICALS LIMITED holds the largest market share at approximately 36% of total trade value on this route.
Q What is the total value of Fulvestrant exports from India to United States?
India exports Fulvestrant to United States worth approximately $4.0M USD across 31 recorded shipments. The average value per shipment is $128.9K USD.
Q Which ports does India use to ship Fulvestrant to United States?
The most active port of origin is SAHAR AIR with 11 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Fulvestrant?
The average transit time for Fulvestrant shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Fulvestrant trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.8% with demand growth tracking at 24.1%. The route is ranked #3 among India's top Fulvestrant export destinations globally.
Q How many suppliers are active on the India to United States Fulvestrant route?
There are currently 12 active Indian suppliers exporting Fulvestrant to United States. The market is moderately concentrated with ALEMBIC PHARMACEUTICALS LIMITED accounting for 36% of total shipment value.
Q Who are the main importers of Fulvestrant from India in United States?
The leading importers of Indian Fulvestrant in United States include J KNIPPER COMPANY, XXNEAXXEU XXMITXX, DR REDDYS LABORATORIES INC, XX REXXY SXXABOXXTORXXS IXX, DR REDDY S LABORATORIES INC. J KNIPPER COMPANY is the largest buyer with 5 shipments worth $1.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Fulvestrant.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 17 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 31 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
31 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists